Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicity in non-small cell lung cancer patients.

Oscar Arrieta; Maria Teresa Vega-Gonzalez; Diego Lopez-Macias; Omar Macedo; Ludwing Bacon Fonseca; Diana Flores Estrada

doi:10.1200/jco.2014.32.15_suppl.8094

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicity in non-small cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.8094 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 8094-8094

Author(s):

Oscar Arrieta ◽

Maria Teresa Vega-Gonzalez ◽

Diego Lopez-Macias ◽

Omar Macedo ◽

Ludwing Bacon Fonseca ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Skin Toxicity ◽

Small Cell ◽

Preventive Effect ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients ◽

Open Label Trial

Download Full-text

Randomized, open-label trial evaluating the preventive effect of tetracycline on afatinib induced-skin toxicities in non-small cell lung cancer patients

Lung Cancer ◽

10.1016/j.lungcan.2015.03.019 ◽

2015 ◽

Vol 88 (3) ◽

pp. 282-288 ◽

Cited By ~ 31

Author(s):

Oscar Arrieta ◽

María Teresa Vega-González ◽

Diego López-Macías ◽

Jorge Negueb Martínez-Hernández ◽

Ludwing Bacon-Fonseca ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Preventive Effect ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients ◽

Open Label Trial

Download Full-text

P3.10-006 The Efficacy of Pistacia Terebinthus Soap in the Treatment of Erlotinib-Induced Skin Toxicity in Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2017.09.1726 ◽

2017 ◽

Vol 12 (11) ◽

pp. S2312

Author(s):

D. Tastekin

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Skin Toxicity ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Pistacia Terebinthus

Download Full-text

Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial

Lung Cancer ◽

10.1016/j.lungcan.2019.06.001 ◽

2019 ◽

Vol 134 ◽

pp. 274-278 ◽

Cited By ~ 17

Author(s):

Daichi Fujimoto ◽

Makiko Yomota ◽

Akimasa Sekine ◽

Mitsunori Morita ◽

Takeshi Morimoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Interstitial Pneumonia ◽

Phase Ii ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients

Download Full-text

An open-label, multicenter, phase II single arm trial of osimertinib in non-small cell lung cancer patients with uncommon EGFR mutation (KCSG-LU15-09).

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.9050 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 9050-9050 ◽

Cited By ~ 5

Author(s):

Myung-Ju Ahn ◽

Jang Ho Cho ◽

Jong-Mu Sun ◽

Se-Hoon Lee ◽

Jin Seok Ahn ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii ◽

Egfr Mutation ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients ◽

Multicenter Phase

Download Full-text

Plasma MIP-1β levels and skin toxicity in Japanese non-small cell lung cancer patients treated with the EGFR-targeted tyrosine kinase inhibitor, gefitinib

Lung Cancer ◽

10.1016/j.lungcan.2005.07.012 ◽

2005 ◽

Vol 50 (3) ◽

pp. 393-399 ◽

Cited By ~ 9

Author(s):

Hideharu Kimura ◽

Kazuo Kasahara ◽

Masaru Sekijima ◽

Tomohide Tamura ◽

Kazuto Nishio

Keyword(s):

Lung Cancer ◽

Tyrosine Kinase ◽

Small Cell Lung Cancer ◽

Tyrosine Kinase Inhibitor ◽

Cancer Patients ◽

Kinase Inhibitor ◽

Skin Toxicity ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

P1.01-32 A Multicenter, Open-Label, Phase II Trial of S-1 Plus Carboplatin in Advanced Non-Small Cell Lung Cancer Patients with Interstitial Lung Disease

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.588 ◽

2018 ◽

Vol 13 (10) ◽

pp. S472

Author(s):

M. Hanibuchi ◽

S. Kakiuchi ◽

S. Atagi ◽

F. Ogushi ◽

E. Shimizu ◽

...

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients ◽

Open Label Phase

Download Full-text

A multicenter, open-label, phase II trial of S-1 plus carboplatin in advanced non-small cell lung cancer patients with interstitial lung disease

Lung Cancer ◽

10.1016/j.lungcan.2018.09.007 ◽

2018 ◽

Vol 125 ◽

pp. 93-99 ◽

Cited By ~ 6

Author(s):

Masaki Hanibuchi ◽

Soji Kakiuchi ◽

Shinji Atagi ◽

Fumitaka Ogushi ◽

Eiji Shimizu ◽

...

Keyword(s):

Lung Cancer ◽

Interstitial Lung Disease ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Phase Ii Trial ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Lung Cancer Patients ◽

Open Label Phase

Download Full-text

Multicenter open label study of epoetin beta prevention and treatment for anaemia in non-small cell lung cancer patients treated with chemotherapy prone to induce anaemia

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.20743 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 20743-20743

Author(s):

J. Yang ◽

Y. Wu ◽

D. Yu ◽

C. Huang ◽

C. Zhou ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Small Cell ◽

Small Cell Lung ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Lung Cancer Patients ◽

Prevention And Treatment

Download Full-text

CYTAR: A randomized clinical trial evaluating the preventive effect of doxycycline on erlotinib-induced folliculitis in non-small cell lung cancer patients.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.9019 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 9019-9019 ◽

Cited By ~ 12

Author(s):

G. Deplanque ◽

J. Chavaillon ◽

A. Vergnenegre ◽

L. Falchero ◽

G. Fraboulet ◽

...

Keyword(s):

Lung Cancer ◽

Clinical Trial ◽

Small Cell Lung Cancer ◽

Randomized Clinical Trial ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Small Cell ◽

Preventive Effect ◽

Small Cell Lung ◽

Lung Cancer Patients

Download Full-text

Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2916-3 ◽

2015 ◽

Vol 77 (1) ◽

pp. 205-209 ◽

Cited By ~ 24

Author(s):

Mariamena Arbitrio ◽

Maria Teresa Di Martino ◽

Vito Barbieri ◽

Giuseppe Agapito ◽

Pietro Hiram Guzzi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Microarray Analysis ◽

Cell Lung Cancer ◽

Skin Toxicity ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

Polymorphic Variants

Download Full-text